Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Selective blockade of the mutated BRAF leads to a survival benefit in patients with metastatic melanoma].

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG - 1 Apr 2011

Schadendorf Dirk

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Germany
Share to Melanoma
Share to Proto-Oncogene Proteins B-raf

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Skin Neoplasms

Share to Survival Analysis

Share to Survival Rate

Share to Treatment Outcome

Source

Identifiers

PMID: 21439018
DOI: 10.1111/j.1610-0387.2011.07653.x

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Selective blockade of the mutated BRAF leads to a survival benefit in patients with metastatic melanoma].PMID 21439018Read ↗

[Treatment of BRAF-mutated metastatic melanoma].Semantic proximity Read ↗

[BRAF mutation: a novel approach in targeted melanoma therapy].Semantic proximity Read ↗

[Immunotherapy for BRAF mutant metastatic melanoma.]Semantic proximity Read ↗

Targeting BRAF for patients with melanoma.Semantic proximity Read ↗

BRAF Inhibitors and MelanomaSemantic proximity Read ↗

[Future targeting of the RAS/RAF/MEK/ERK signaling pathway in oncology: the example of melanoma].Semantic proximity Read ↗

Targeted therapy resistance mechanisms and therapeutic implications in melanoma.Semantic proximity Read ↗

Narrative review: BRAF opens the door for therapeutic advances in melanoma.Semantic proximity Read ↗

Therapy of metastatic malignant melanoma: on the way to individualized disease control.Semantic proximity Read ↗

BRAF-MEK inhibition in melanoma brain metastases: a new hope.Semantic proximity Read ↗

[Mechanisms of resistance to anti-BRAF treatments].Semantic proximity Read ↗

Emerging BRAF inhibitors for melanoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.